Signature Wealth Management Partners’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Signature Wealth Management Partners’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,300	Closed	-$24.1K	–	101
2023 Q2	$24.1K	Hold	6,300	–	–	0.02%	97
2023 Q1	$17.6K	Buy	6,300 +604	+11%	+$2.48K	0.02%	106
2022 Q4	$15.3K	Hold	5,696	–	–	0.02%	100
2022 Q3	$27K	Hold	5,696	–	–	0.03%	98
2022 Q2	$60K	Buy	5,696 +1,209	+27%	+$10.5K	0.06%	102
2022 Q1	$61K	Buy	4,487 +500	+13%	+$8.67K	0.05%	112
2021 Q4	$95K	Buy	3,987 +1,987	+99%	+$46.8K	0.08%	106
2021 Q3	$35K	Buy	+2,000	New	+$37.5K	0.03%	110

Other funds holding BTCY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFCL

Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Signature Wealth Management Partners's BTCY Position: Q3 2023 in Review

Signature Wealth Management Partners sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2023, closing a stake of 6,300 shares — an estimated $24.1K sold.

Signature Wealth Management Partners first reported a position in BTCY in Q3 2021 and held it in 8 quarters. The position peaked at $95K in Q4 2021. 22 funds tracked by Wall St. Rank hold BTCY as of Q3 2023.

Signature Wealth Management Partners reported no remaining Biotricity, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Signature Wealth Management Partners sold 6,300 Biotricity, Inc. Common Stock shares in Q3 2023, an estimated $24.1K.
Signature Wealth Management Partners first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Signature Wealth Management Partners's Biotricity, Inc. Common Stock position peaked at $95K in Q4 2021.
22 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2023.

Based on Signature Wealth Management Partners's 13F filing for Q3 2023, filed 24 Oct 2023.